Cargando…

An artesunate pharmacometric model to explain therapeutic responses in falciparum malaria

BACKGROUND: The artemisinins are potent and widely used antimalarial drugs that are eliminated rapidly. A simple concentration–effect pharmacometric model does not explain why dosing more frequently than once daily fails to augment parasite clearance and improve therapeutic responses in vivo. Artemi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saralamba, Sompob, Simpson, Julie A, Choosri, Noppon, White, Lisa, Pan-Ngum, Wirichada, Dondorp, Arjen M, White, Nicholas J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477127/ https://www.ncbi.nlm.nih.gov/pubmed/37473441 http://dx.doi.org/10.1093/jac/dkad219

Ejemplares similares

The role of mathematical modelling in malaria elimination and eradication (Comment on: Can malaria be eliminated?)
por: Maude, Richard J., et al.
Publicado: (2009)

Artesunate Dosing in Severe Falciparum Malaria
por: Dondorp, Arjen M., et al.
Publicado: (2012)

The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia
por: Maude, Richard J, et al.
Publicado: (2009)

The role of mathematical modelling in guiding the science and economics of malaria elimination
por: Maude, Richard J., et al.
Publicado: (2010)

Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting
por: Kinyanjui, Timothy, et al.
Publicado: (2020)

Determinants of MDA impact and designing MDAs towards malaria elimination
por: Gao, Bo, et al.
Publicado: (2020)

Modelling malaria elimination on the internet
por: Maude, Richard J, et al.
Publicado: (2011)

Classification of elderly pain severity from automated video clip facial action unit analysis: A study from a Thai data repository
por: Gomutbutra, Patama, et al.
Publicado: (2022)

Probability of emergence of antimalarial resistance in different stages of the parasite life cycle
por: Pongtavornpinyo, Wirichada, et al.
Publicado: (2009)

The role of simple mathematical models in malaria elimination strategy design
por: White, Lisa J, et al.
Publicado: (2009)

Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance
por: White, Nicholas J, et al.
Publicado: (2009)

A Dynamic Stress Model Explains the Delayed Drug Effect in Artemisinin Treatment of Plasmodium falciparum
por: Cao, Pengxing, et al.
Publicado: (2017)

Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria
por: Jamsen, Kris M, et al.
Publicado: (2011)

WHO should accelerate, not stall, rectal artesunate deployment for pre-referral treatment of severe malaria
por: Peto, Thomas J, et al.
Publicado: (2023)

Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach
por: Pan-Ngum, Wirichada, et al.
Publicado: (2017)

How to model the impact of vaccines for policymaking when the characteristics are uncertain: A case study in Thailand prior to the vaccine rollout during the COVID-19 pandemic
por: Luangasanatip, Nantasit, et al.
Publicado: (2023)

Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction
por: Awab, Ghulam Rahim, et al.
Publicado: (2016)

Defining the In Vivo Phenotype of Artemisinin-Resistant Falciparum Malaria: A Modelling Approach
por: White, Lisa J., et al.
Publicado: (2015)

Counterfeit artesunate antimalarials in southeast Asia
por: Newton, Paul N, et al.
Publicado: (2003)

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial
por: Dondorp, Arjen M, et al.
Publicado: (2010)

Effect of High-Dose or Split-Dose Artesunate on Parasite Clearance in Artemisinin-Resistant Falciparum Malaria
por: Das, Debashish, et al.
Publicado: (2013)

Severe falciparum malaria treated with artesunate complicated by delayed onset haemolysis and acute kidney injury
por: Plewes, Katherine, et al.
Publicado: (2015)

The diminishing returns of atovaquone-proguanil for elimination of Plasmodium falciparum malaria: modelling mass drug administration and treatment
por: Maude, Richard J, et al.
Publicado: (2014)

Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic
por: Wang, Yi, et al.
Publicado: (2022)

Estimation of the Total Parasite Biomass in Acute Falciparum Malaria from Plasma PfHRP2
por: Dondorp, Arjen M, et al.
Publicado: (2005)

Randomized controlled trial of artesunate or artemether in Vietnamese adults with severe falciparum malaria
por: Phu, Nguyen H, et al.
Publicado: (2010)

Correction: Estimation of the Total Parasite Biomass in Acute Falciparum Malaria from Plasma PfHRP2
por: Dondorp, Arjen M, et al.
Publicado: (2005)

Limited Polymorphism of the Kelch Propeller Domain in Plasmodium malariae and P. ovale Isolates from Thailand
por: Nakeesathit, Supatchara, et al.
Publicado: (2016)

Post-treatment haemolysis in African children with hyperparasitaemic falciparum malaria; a randomized comparison of artesunate and quinine
por: Fanello, C., et al.
Publicado: (2017)

Stopping prereferral rectal artesunate — a grave error
por: Watson, James A, et al.
Publicado: (2022)

Deployment of Early Diagnosis and Mefloquine- Artesunate Treatment of Falciparum Malaria in Thailand: The Tak Malaria Initiative
por: Carrara, Verena Ilona, et al.
Publicado: (2006)

Feasibility study of using mobile application to support triage and diagnosis clinical decisions for pediatricians: User-centered design approach
por: Choosri, Noppon, et al.
Publicado: (2023)

Investigating causal pathways in severe falciparum malaria: A pooled retrospective analysis of clinical studies
por: Leopold, Stije J., et al.
Publicado: (2019)

Does Artesunate Prolong the Electrocardiograph QT Interval in Patients with Severe Malaria?
por: Maude, Richard J., et al.
Publicado: (2009)

Reversibility of Retinal Microvascular Changes in Severe Falciparum Malaria
por: Maude, Richard J., et al.
Publicado: (2014)

Ethics, Economics, and the Use of Primaquine to Reduce Falciparum Malaria Transmission in Asymptomatic Populations
por: Lubell, Yoel, et al.
Publicado: (2014)

Diagnosing Severe Falciparum Malaria in Parasitaemic African Children: A Prospective Evaluation of Plasma PfHRP2 Measurement
por: Hendriksen, Ilse C. E., et al.
Publicado: (2012)

A Randomized Comparison of Dihydroartemisinin-Piperaquine and Artesunate-Amodiaquine Combined With Primaquine for Radical Treatment of Vivax Malaria in Sumatera, Indonesia
por: Pasaribu, Ayodhia Pitaloka, et al.
Publicado: (2013)

Human population movement and behavioural patterns in malaria hotspots on the Thai–Myanmar border: implications for malaria elimination
por: Saita, Sayambhu, et al.
Publicado: (2019)

Identifying artemisinin resistance from parasite clearance half-life data with a simple Shiny web application
por: Tun, Sai Thein Than, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_79cg8ftovmdro66v8gcn7meirs